Cargando…
Immunopathology of Hyperinflammation in COVID-19
The rapid spread of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), has resulted in an unprecedented public health crisis worldwide. Recent studies indicate that a hyperinflammatory syndrome induced by SARS-CoV-2 contributes to disease sev...
Autores principales: | Gustine, Joshua N., Jones, Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Investigative Pathology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484812/ https://www.ncbi.nlm.nih.gov/pubmed/32919977 http://dx.doi.org/10.1016/j.ajpath.2020.08.009 |
Ejemplares similares
-
Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infection
por: Rosli, Sarah, et al.
Publicado: (2023) -
Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
por: Tanner, Tamara, et al.
Publicado: (2020) -
Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022) -
COVID-19 Hyperinflammation: What about Neutrophils?
por: Didangelos, Athanasios
Publicado: (2020) -
Frontal encephalopathy related to hyperinflammation in COVID-19
por: Cani, Ilaria, et al.
Publicado: (2020)